Skip to content

In the BioHarmony Drug Report Database

Carglumic acid

Carbaglu (carglumic acid) is a small molecule pharmaceutical. Carglumic acid was first approved as Carbaglu on 2003-01-24. It is used to treat hyperammonemia in the USA. It has been approved in Europe to treat hyperammonemia, inborn errors amino acid metabolism, and propionic acidemia.
Trade Name Carbaglu
Common Name Carglumic acid
Indication hyperammonemia, inborn errors amino acid metabolism, propionic acidemia
Drug Class
Carglumic acid
Get full access now